Cargando…
Incidence and predictors for abnormal liver function during direct-acting antiviral agents in chronic hepatitis C patients
Abrupt alanine aminotransferase (ALT) elevation during direct-acting antiviral agents (DAA) treatment is an uncommon but noticeable adverse event in chronic hepatitis C (CHC) patients, which may lead to early termination of treatment. This study aims to investigate the incidence, outcome and predict...
Autores principales: | Liu, Yen-Chun, Jeng, Wen-Juei, Cheng, Ya-Ting, Hsieh, Yi-Chung, Teng, Wei, Chen, Yi-Cheng, Lin, Chun-Yen, Chien, Rong-Nan, Sheen, I-Shyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489670/ https://www.ncbi.nlm.nih.gov/pubmed/32925725 http://dx.doi.org/10.1097/MD.0000000000021898 |
Ejemplares similares
-
Predictors of Mortality Within 6 Weeks After Treatment of Gastric Variceal Bleeding in Cirrhotic Patients
por: Teng, Wei, et al.
Publicado: (2014) -
Hepatitis B Co-Infection Has Limited Impact on Liver Stiffness Regression in Chronic Hepatitis C Patients Treated with Direct-Acting Antivirals
por: Hsu, Cheng-Er, et al.
Publicado: (2022) -
Rapid platelet count improvement in chronic hepatitis C patients with thrombocytopenia receiving direct-acting antiviral agents
por: Chen, Yen-Chun, et al.
Publicado: (2020) -
Interferon Is Superior to Direct Acting Antiviral Therapy in Tertiary Prevention of Early Recurrence of Hepatocellular Carcinoma
por: Teng, Wei, et al.
Publicado: (2019) -
Dynamic noninvasive markers predict hepatocellular carcinoma in chronic hepatitis C patients without sustained virological response after interferon-based therapy: Prioritize who needs urgent direct-acting antiviral agents
por: Huang, Chao-Min, et al.
Publicado: (2017)